SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Valentis (VLTS)
 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext  
To: Mike McFarland who wrote ()4/27/1999 12:07:00 AM
From: Mike McFarland  Read Replies (1) of 81
 
Bridge Technology Group LLC Announces Investment Opinion
biz.yahoo.com
Megabios (Valentis) (NASDAQ:MBIO - news): a gene therapy
company that recently merged with GeneMedicine to create Valentis,
a leader in the development of plasmid-based gene medicines. Bridge
Technology believes the merger to be extremely synergistic --
creating a company with seven products in clinical trials and a
pipeline behind them, strong corporate partnerships, an excellent
balance sheet and a low cash burn rate.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News